Loading
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
$4.085
+$0.045 · +1.11%
Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.
Previous close
$4.085
+$0.045 · +1.11%
After-hours
$4.085
$0.00 · 0.00%
Oct 8, 7:30 PM ET
Regular session · ET · Market data may be delayed.
Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.
Day range
Current $4.085
52-week range
Current $4.085
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
27
Expensive
Sentiment
48
Mixed
Risk
63
High Risk
Momentum
31
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Based in Princeton, Canada, Optimi Health Corp., established in 2020, is a Canadian entity focused on manufacturing pharmaceutical and nutraceutical products. The company produces and supplies controlled substances, including finalized MDMA and psilocybin drug products, directly to authorized clinics, pharmacies, research trials, and collaborative partners. Their diverse product portfolio extends to MDMA, natural psilocybin, psilocin, other psychedelic compounds, and functional mushrooms, all derived from botanical sources and aimed at the health and wellness market. Optimi Health's operations span cultivation, processing, and distribution of raw mushroom biomass, alongside the creation of mushroom extracts, pharmaceutical drug products, and dietary supplements. These items are available for purchase through the Amazon marketplace, via distributors and brokers, and directly online.
Day range
Current $4.085
52-week range
Current $4.085
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CAD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 426.9K CAD | 389.85K CAD | 181.09K CAD | 80.72K CAD | — |
| Cost of goods sold | 2.5M CAD | 118.94K CAD | 338.12K CAD | 26.8K CAD | — |
| Gross profit | −2.08M CAD | 270.91K CAD | −157.04K CAD | 53.92K CAD | — |
| Research and development | 348.19K CAD | 144.47K CAD | 152.15K CAD | 133.24K CAD | 240.92K CAD |
| Selling, general, and administrative | 2.72M CAD | 3.99M CAD | 3.93M CAD | 6.14M CAD | 5.06M CAD |
| Operating expenses | 2.46M CAD | 5.88M CAD | 4.22M CAD | 7.44M CAD | 6.06M CAD |
| Interest income | 14.33K CAD | 2.67K CAD | 136.41K CAD | 66.94K CAD | 55.04K CAD |
| Interest expense | 532.43K CAD | 429.34K CAD | 43.71K CAD | 27.99K CAD | 19.18K CAD |
| Depreciation and amortization | 950.35K CAD | 867.95K CAD | 729.56K CAD | 293.6K CAD | 47.12K CAD |
| Operating income | −4.53M CAD | −5.61M CAD | −4.38M CAD | −7.39M CAD | −6.06M CAD |
| Net income | −3.72M CAD | −6.04M CAD | −5.19M CAD | −7.35M CAD | −6.02M CAD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
| Action | Effective date | Details | Record date | Payment date |
|---|---|---|---|---|
Stock split | May 20, 2026 | 1:30 | — | — |
Effective May 20, 2026
1:30
Funds reporting this stock among their holdings, ordered by reported position size.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
